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According to Preissner et ai., the carboxy-terminal (C-terminal) domain contains
regions of binding for both heparin and PAl-I, however they do not appear to be one in the
same (6, 7). The heparin-binding region of vitronectin starts with residue 341 of the C
terminal domain. Through residue 379, the sequence contains many positively charged
amino acids, no acidic residues, and few hydrophobic residues (3).
Since the C-terminal domain is of such great physiological importance, the production
of a recombinant fonn of the C-tenninal domain is ideal for characterizing the interactions
of vitronectin. The clones used in the experiment had been inserted with a fragment of
vitronectin consisting of residues 331 through 439. This fragment is highly basic, having a
pK over 11, and thus it is presumed to be soluble once expressed as a protein. It is of
utmost importance to express the recombinant C-terminal domain in a soluble form.
Recombinant vitronectin found in inclusion bodies is of very limited use since the protein
will have to undergo harsh denaturing steps to free the recombinant vitronectin. Treatment
with reagents such as 8M urea results in an altered protein (8). In order to have the most
physiologically relevant and therefore active form of vitronectin, the over-expressed
recombinant vitronectin must be soluble.

MATERIALS AND METHODS
Materials
The pET System by Novagen (Madison, WI) was used for cloning and expressing the
C-terminal domain of the vitronectin protein. The gene for the C-terminal domain of
vitronectin had been previously cloned into a plasmid pET vector from Novagen (Madison,
WI) by workers in Dr. Peterson's lab.

The two clones used in the experiment were

pET23dVN and pET22bVN. The inducer, isopropylthio-B -D-galactoside (IPTG) was
from GibcoBRL (New York). Electrophoresis-grade reagents for polyacrylamide gel
electrophoresis, Kaleidoscope molecular weight standard, and the nitrocellulose transfer
paper were all from Bio-Rad Laboratories (Hercules, CA). The rabbit anti-vitronectin
antibody was purchased from Rockland (Gilbertsville,PA), and the goat anti-rabbit IgG
conjugated with horseradish peroxidase was purchased from Vector (Burlington, CA). All
other reagents were reagent grade.
Transfonnation

To use the BL21 Expression system, pET23dVN and pET22b VN vectors are
transformed into competent BL21 (DE3)pLysS E. coli. strain. The protocol suggested in
the pET System Manual was followed. The competent cells were removed from the -80°C
freezer and allowed to thaw in an ice bucket. Once thawed, 1 J.1L of plasmid DNA, either
pET23dVN or pET22bVN, was gently mixed with a pipette. After an incubation period of
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30 minutes, the mixture was "heat shocked" for exactly 40 seconds in a 42°C water bath.
The cells were placed back on ice for 2 minutes. 80 JlLs of LB media was added to the
transformation mixture and then incubated for 1 hour in the 37°C room with shaking.
Next, 50 J.1Ls of the cells were spread on LB-ampicillin plate, aseptically. Then, the plates
were inverted and allowed to grow overnight in the 37°C room.
Inoculation

Since the vitronectin clone contained the gene B-Iactamase coding for ampicillin
resistance, only those colonies that had the plasmid inserted into them will be able to thrive
in the ampicillin-containing media. Therefore, one screening step had already been
performed. Colonies were randomly picked with sterile, wooden sticks from some of the
plates to inoculate the media. The colonies were grown overnight at 37°C with shaking in a
test tube containing 2 mLs of LB with ampicillin and chloramphenicol antibiotics. Also, a
sample was started containing 2 mLs of LB with only chloramphenicol with untransformed
BL21(DE3)pLysS cells.
Induction

The next morning, 1 mL of LB containing the appropriate antibiotic was placed into four
test tubes. This was done for every culture started the previous day. To each 1 mL LB
antibiotic mixture, 25 JlLs from the appropriate overnight culture was added. These new
samples were then placed in the 37°C room with shaking and allowed to grow until mid-log
phase was reached. Mid-log phase was judged by visual inspection of the overall
cloudiness of the of the bacteria sample. Once the stock reached mid-log phase, 10 JlLs of
a 100 mM stock of IPTG was added to one sample. Another stock had 5 JlLs of rifampicin
added, and a third had both IPTG and rifampicin added. These cultures were grown
overnight in the 37°C room.
Screening

The next day, 0.5 mLs of cells from each culture was placed in separate, labeled
eppendorfs. Next, the cultures were spun in the microcentrifuge for 5 minutes, and the
supernatant was removed. The cells were resuspended in l00JlLs of SDS-PAGE loading
dye and were then boiled for 5 minutes. Next, 10 JlLs of each sample was loaded on a
15% polyacrylamide SDS gel. The gels were run at 150 V until the loading dye reached the
bottom. The gel was stained with Coomassie brilliant blue and then destained. A band
appearing to have a molecular weight of between 17,000 to 20,000 was deemed to be the
over-expressed C-terminal of the vitronectin protein. The actual fragment of vitronectin is
around 19 kDa. A Western blot was performed to verify the results.
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The Western blot consisted of transferring a 15% SOS polyacrylamide gel with the Bio
Rad Trans-Blot SO system to nitrocellulose paper with 25 V for 45 minutes. The paper
was blocked in 10% milk and later washed. Anti-vitronectin antibody in a 2% milk
solution was poured onto the nitrocellulose paper and later washed. Then, the enzyme
linked secondary antibody, goat anti-rabbit IgG conjugated with horseradish peroxidase
was added to the nitrocellulose paper and later washed. Finally, developing fluid
containing the substrate 30% hydrogen peroxide was added to expose the presence of
vitronectin.

Optimization
Oifferent conditions were used to grow up the cultures that were determined to over
express. The same protocol was used to inoculate and induce these samples, except that
the rifampicin samples were omitted. Also, one sample was placed in a 0.4 M N aCI LB
media with ampicillin and chloramphenicol instead of the standard LB and antibiotic media
used throughout the experiment.

5 mLs of LB and antibiotic media were induced as

previously described. Next, the samples were grown in the following conditions: 37°C,
room temperature approximately 25°C, and IS0C. The culture in the 0.4 M NaCI LB media
was grown at 37°C. All samples were grown with shaking. Time points were taken at the
following times: 4, 16, 2S, 40, and 66 hours.

At each time point, 1 mL of media was

placed in a labeled eppendorf and spun in a microcentrifuge. The supernatant was removed
and the cells were frozen away. SOS-PAGE gels were run on the 4 and 16 hour time
points in the same manner as previously described.

Crude extractions
Cell extracts were prepared from cells collected at 40 and 66 hours in order to detect
soluble proteins. The 40 hour time point samples were centrifuged and the supernatant was
carefully removed by pipette and discarded. 25 J.1Ls of a solution containing 0.1 M Tris,
pH S.O was added to each of the pellets. The cultures were placed in the -SO°C freezer for
5 minutes and then in the 37°C room for 5 minutes. The freeze-thaw cycle was repeated
twice. Next, the samples were centrifuged for 15 minutes. The supernatant was removed
and placed into labeled eppendorfs. To 10 JlLs of supernatant, an equal volume of SDS
loading dye was added. Next, 25 J.1Ls of S M urea was mixed well with the remaining cell
pellet. After centrifuging for 5 minutes, 10 J.1L of the urea-solubilized pellet was added to
an equal volume of SOS loading dye. Both the supernatant and urea-solubilized mixtures
were boiled and then analyzed on 15% SOS-polyacrylamide gels and Western blots.

lilrge scale protein preparation
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The cultures determined to over-express the C-terminal domain of vitronectin in soluble
form were inoculated into 8 mLs of LB and antibiotic and allowed to grow in the 37°C
room with shaking overnight. 5 mLs of the ove~ght culture were used to inoculate a 200
mL media solution. For controls, 1 mL samples were also inoculated with the overnight

cultures. After 3 hours of growing in the 37°C room, the inoculated media was induced.
The 200 mL culture was induced with IPTG, while half of the 1 mL samples were induced
with IPTG and the others were left alpne. All samples were grown at 18°C with shaking.
A time point was taken at 24 hours in which 1 mL was removed from the 200 mLs
samples, and 0.5 mL from the 1 mL sample. The samples were allowed to grow at 18°C
for 72 hours. The samples taken at the 24 hours and the small scale samples taken at 72
hours underwent the crude extractions as previously described and were analyzed by 15%
SDS-polyacrylamide gels. The large scale samples underwent similar treatment as
described in the pET System Manual. The cultures of induced cells were centrifuged for 5
minutes and the supernatant was discarded. The pellets were resuspended in 1110 culture
volume of 50mM Tris-HCI pH 8.0, 2mM EDTA. No lysozyme was added to the mixture.
Next, the cultures were sonicated while in an ice bath with two 10 second pulses at a high
output setting. Then, the samples were centrifuged for 15 minutes with the supernatant
containing the soluble vitronectin protein and other soluble proteins. Finally, a 15% SDS
polyacrylamide gel and a Western blot were used to analyze the supernatant.

EXPRESSION VECTORS

col 734

gIll" 831
pet23d-VN

4163 bp
Pstl 3023

Pvull 1476

FIGURE 1: The map of the expression vector pET23dVN. This vector contains ampR, ampicillin
resistance which denotes the presence of the B-lactamase gene. The gene for the C-terminal domain of
vitronectin, VNDomain is also encoded. The pET23dVN vector does not contain the pelB gene. Various
restriction sites are also included in the plasmid map.
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Pst! 4853
stXI 1416

pET22b-VN

5993 bp

----

BstXI 1545
BstXI 1668

BstEIi 1795

EcoRV 2064
Pvull 2214
Pvull 2307

Pvul l 3306

FIGURE 2: The map of the expression vector pET22bVN. This vector contains ampR, ampicillin
resistance which denotes the presence of the B-Iactamase gene. The gene for the C-tenninal domain of
vitronectin, VNDomain is also encoded. This vector has a pelB site, which is a leader sequence that directs
secretion of the peptide into periplasm. Various restriction sites are also included in the plasmid map.

RESULTS
Initial Expressions
An SDS-polyacrylamide gel (Figure 3) revealed a band of the expected molecular

weight, suggesting expression of the C-terminal domain of vitronectin. Bands appeared
just above the molecular weight marker of lysozyme (17,800 Da) from the Bio-Rad
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FIGURE 3: A 15% SDS polyacrylamide gel suggesting expression of the C-terminal domain of
vitronectin. Lane 1 - Bio-Rad Kaleidoscope molecular weight standard. Lane 2 - 22b penn4 induced with
IPTG. Lane 3 - 22b perm4 non-induced. Lane 4 - 23d penn2 induced with IPTG. Lane 5 - 23d penn2
non-induced.

Kaleidoscope standard where expression the 19,000 Da C-terminal domain fragment of
vitronectin would be thought to be found.
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Rifampicin was unsuccessful in every attempt to increase the expression a significant
amount of vitronectin C-terminal domain. Only a decrease in total protein production was
noted. The amount of growth was greatly reduced compared with those cultures not
induced and those induced with IPTG. As a result, rifampicin was not added to any
cultures later in the experiment.
The cultures of 22b perm4 and 23d perm2 were chosen for the optimization
experiments. SDS polyacrylamide gels (Figure 4) run on samples taken at the 4 hour point
showed possible expression of the samples induced with only IPTG grown at 37°C,
including the samples grown in OAM NaCI LB media.
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FIGURE 4: A 15% SDS polyacrylamide gel of 22b perm4 at 37°C for the 4 hour samples. Lane I - Bio
Rad Kaleidoscope molecular weight standard. Lane 2 - Induced with IPTG. Lane 3 - Non-induced in OAM
NaCI LB . Lane 4 - Induced with IPTG in AM NaCI LB .

SDS polyacrylamide gels were also run on samples taken at the 16 hour time point.
However, no accurate results can be acquired from analyzing these gels.

Crude Extraction Results
The samples taken from the 40 hour time point underwent crude extractions. The
supernatants of these samples were run on SDS polyacrylru:nide gels (Figure 5). In lane 3
of Figure 5, expression of the C-terminal domain seemed to occurr in the supernatant from
22b perm4 culture induced with IPTG at 18°C. The supernatant of 22b perm4 induced
with IPTG at 25°C also strikingly reveals a band at the approximate molecular weight of the
vitronectin fragment. Moreover, all samples grown at 37°C seem to have expressed the
vitronectin C-terminal domain, including the non-induced samples. An example is seen in
lane 4 of Figure 5.
The supernatant of the 23d perm2 samples run on an SDS polyacrylamide gel (Figure 5)
were less revealing. When removing the supernatant from the cell pellet, it became
impossible to separate the two. No supernatant was recovered for 23d perm2 induced with
IPTG at 18°C and 25°C. The bands appeared identical that denoted vitronectin from the
37°C samples that were non-induced, induced with IPTG, and induced with IPTG and

7

rifampicin. The 23d perm2 samples grown in 0.4 M NaCI LB at 37°C had bands at the
vitronectin fragment molecular weight which appeared at different intensities. The sample
induced with IPTG was darkest. A lighter band appeared in the non-induced sample, while
a very faint band appeared in the 23d perm2 sample induced with both IPTG and
rifampicin.
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FIGURE 5: A 15% SDS polyacrylamide gel of the crude extract from 40 hour samples. Lane 1 - Bio-Rad
Kaleidoscope molecular weight standard. Lane 2 - supernatant of 22b penn4 non-induced at 18°C. Lane 3 
supernatant of 22b penn4 induced with IPTG at 18°C. Lane 4 - supernatant of 22b penn 4 non-induced at
37°C. Lane 5 - supernatant of O.4M NaCI non-induced at 37°C. Lane 6 - supernatant of 0.4M NaCl
induced with IPTG at 37°C. Lane 7 - supernatant of.4M NaCI induced at 37°C with IPTG and rifampicin.

The supernatant of the 23d perm2 samples run on an SDS polyacrylamide gel were less
revealing. When removing the supernatant from the cell pellet, it became impossible to
separate the two. No supernatant was recovered for 23d perm2 induced with IPTG at 18°C
and 25°C. The bands denoting the vitronectin fragment from samples grown at 37°C that
were non-induced, induced with IPTG, and induced with IPTG and rifampicin appeared
identical. The 23d perm2 samples grown in 0.4 M NaCI LB at 37°C had bands at the
vitronectin fragment molecular weight which appeared at different intensities. The sample
induced with IPTG was darkest. A lighter band appeared in the non-induced sample, while
a very faint band appeared in the 23d perm2 sample induced with IPTG and rifampicin.
Analysis by Western blots of the supernatants from the 40 hour samples 22b perm4
(Figure 6) and 23d perm2 reveal some cross reaction of the primary antibody with other
proteins in the 40 hour samples. The Western blot of 22b perm4 produced dark distinct
bands denoting the presence of vitronectin in all samples grown at 37°C except for those
induced with IPTG and rifampicin. The D.4M NaCI LB at 37°C samples did not produce
band as dark as the corresponding samples in standard LB at 37°C. The 22b perm4
samples at 25°C and 18°C, however, did show different intensities of the vitronectin band,
especially between the induced with IPTG and non-induced (Figure 6). The Western blot
of the supernatant from the 23d perm2 40 hour sample was not as conclusive. All the
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samples at 37°C reacted strongly with the antibodies and produced dark and distinct bands.
However, the induced with IPTG samples at 37°C from both standard and high salt media
produced slightly darker bands. The 25°C and 18°C samples cannot be commented on since
2
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FIGURE 6: Western blot of the crude extract at 40 hours of 22b perm4 at 18°C - 15% SDS
polycarylamide gel transferred to nitrocellulose and reacted with antibodies specific for vitronectin. Lane 1 Bio-Rad Kaleidoscope molecular weight standard. Lane 2 - Non-induced. Lane 3 - Induced with IPTG.

neither one has a sample induced with IPTG to compare with. The results of both SDS
polyacrylamide gels and Western blots showed that vitronectin was in a soluble form in the
supernatant.
SDS polyacrylamide gels were also run on 22b perm4 and 23d perm2 that had been
solubilized in 8M urea. The 23d perm2 samples revealed differences between induced and
non-induced in the levels of expression at 18°C. Slight differences were detected between
the induced and non-induced samples at 25°C and 37°C in high salt. No differences were
detected between the induced and non-induced samples at 37°C. The 22b perm4 samples
had similar results. Western blots were performed and confirmed the results of the SDS
PAGE. Therefore, vitronectin appears also to be insoluble as seen by the gels from the
urea pellets.
An SDS polyacrylamide gel of the 66 hour samples by Dr. C. Peterson confmned the
results of the analysis of the 40 hour samples. One gel revealed a high level of expression
of the supernatant in the induced 22d perm4 18°C sample as did the corresponding sample
from the urea pellet.

However, all samples, induced and non-induced, of urea pellets

grown at 37°C including the O.4M NaCI LB samples produced consistent and dark bands
representing expression of the C-terminal domain of vitronectin. Once again, the 18°C
samples seemed to produce more distinct differences than samples at 37°C. The results
from the electrophoretic analysis of the 22b perm4 urea pellets and supernatants from the
66 hour sample were not very conclusive.

Large-scale growth results
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With the apparent success of the production of a soluble vitronectin C-terminal domain
at 18°C as seen from previous analysis by SDS polyacrylamide gels and Westerns blots,
large scale (200 mLs) cultures were started.

Since little success was achieved using

rifampicin, only IPTG was used. A 24 hour time point was taken on both the large and
small cultures growing at 18°C. An analysis of an SDS polyacrylamide gel (Figure 7)
revealed possible vitronectin fragments of both 22b and 23d cultures that had only been
treated with IPTG. However, the protein appeared much fainter in the supernatant samples
than in the urea pellet samples.
MW kDa
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FIGURE 7: A 15% SDS polyacrylamide gel of samples taken at 24 hours at 18°C. Lane 1 - 22b perm4
induced with IPTG urea pellet. Lane 2 - 22b perm4 non-induced urea pellet. Lane 3 - Bio-Rad
Kaleidoscope molecular weight standard. Lane 4 - 23d perm2 non-induced supernatant. Lane 5 - 23d perm2
induced with IPTG supernatant

The Western blot of this gel (Figure 8), Western blot 5, was from the supernatant of
both 22b perm4 and 23d perm2. Both contained very little vitronectin. Only lane 1
appears to have vitronectin present. On the other hand, the urea pellet samples appeared to
have a tremendous amount of vitronectin. From this data, it is probable that more
vitronectin is in the insoluble form, but there is still some present in soluble form.
MW kDa
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FIGURE 8: Western blot of samples taken at 24 hours. Lane 1 - 22b perm4 supernatant induced with
IPTG. Lane 2 - Bio-Rad Kaleidoscope molecular weight standard. Lane 2 - 23d perm4 urea pellet induced
with IPTG.
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After 72 hours of growing at 18°C, the experiment was ceased. From analysis on SDS
polyacrylamide gels (Figure 9), vitronectin C-terminal domain fragments were visualized
clearly in the large scale samples. However, the small scale samples did not produce
distinct bands corresponding to the molecular weight of the vitronectin fragment. In order
to remove DNA and other elements creating viscosity, the large-scale cultures underwent
sonication and crude extraction as described in the methods. These steps produced a
viscous-free supernatant which made separation from the supernatant facile. The presence
of a soluble form of the recombinant C-terminal domain is presumed from analysis of the
SDS polyacrylamide gel.
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FIGURE 9: A 15% SDS polyacrylamide gel of the supernatant after sonication and crude extraction. Lane
1 - Bio-Rad Kaleidoscope molecular weight standard. Lane 2 - 22b penn4 non-induced. Lane 3 - 23d penn2
non-induced. Lane 4 - 22b penn4 induced with IPTG. Lane 5 - 23d penn2 induced with IPTG.

The Western blot of the same samples performed by Dr. C. Peterson also gave evidence of
vitronectin in the large scale growth samples at 18°C.
MW kDa
139

2

3

4

5

~

84~

41

~

~
17~

Over-expressed vitronectin

.

FIGURE 10: A Western blot of the supernatant after sonication and crude extraction. Lane 1 - Bio-Rad
Kaleidoscope molecular weight standard. Lane 2 - 22b perm4 non-induced. Lane 3 - 23d perm2 non
induced. Lane 4 - 22b perm4 induced with IPTG. Lane 5 - 23d penn2 induced with IPTG.
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DISCUSSION
The carboxy-terminal domain of vitronectin was over-expressed by using the
BL21(DE3)pLysS strain of E. coli. strain from Novagen, Inc. The recombinant plasmids
pET23dVN and pET22b VN made by workers in Dr. C. Peterson's lab were transferred
into the host bacteria cells. The host bacterial cells contained a chromosomal copy of the
gene for T7 RNA polymerase. These hosts were lysogens of bacteriophage DE3, a lambda
derivative that has the immunity region of phage 21 and carried a DNA fragment containing
the lac! gene, the lacUV5 promoter, and the gene for the T7 RNA polymerase (9). The
fragment prevented DE3 from integrating into or excising from the chromosome without a
helper phage once inserted into the in! gene. The only promoter known to direct
transcription of the T7 RNA polymerase gene, once a DE3 lysogen was formed, was the
lacUV5 promoter. The lacUV5 was induced by isopropyl-B-D-thiogalactopyranoside

(IPTG). The addition of IPTG to a growing culture of the lysogen induced T7 RNA
polymerase, which in turn transcribed the target DNA in the plasmid (10).
The ADE3 lysogen of the strain BL21 (F-ompT rB-mB-) was a very suitable host for
target gene expression since it lacked the Ion protease and theompT outer membrane
protease that can degrade proteins during purification (11). The addition of rifampicin to
the BL21 culture was hypothesized as one way to improve expression since BL21 is
sensitive to it. Rifampicin inhibited transcription by the host RNA polymerase in order to
reduce the background synthesis of host RNA and proteins (10). With 22b perm4 and 23d
perm2, rifampicin not only reduced expression of the host proteins, but also reduced
expression of vitronectin.
It is important to note that in the absence of IPTG (non-induced), there can still be
expression ofT7 RNA polymerase from the lacUV5 promoter in ADE3lysogens (10). In
cases of cultures of 37°C was this a problem; however, at 18°C the problem of expression
without the presence of IPTG was greatly reduced.
Additional stability was provided to the target genes by expressing them in host strains
containing a compatible plasmid that provided a small amount of a natural inhibitor of T7
RNA polymerase, T7 lysozyme (12,13). T7 lysozyme was able to cut a specific bond in
the peptidoglycan layer of the E. coli cell wall and bound to T7 RNA polymerase inhibiting
transcription (14). High levels of the T7 lysozyme can be tolerated by E. coli since the
protein was unable to pass through the inner membrane to reach the peptidoglycan layer. A
freeze-thaw cycle was used in the experiment to induce cell lysis by disrupting the inner
membrane of the cells.
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The pLysS was important to the BL21 system. First, it was the fragment in the plasmid
that produced the T7 lysozyme. From a clone of the T7 lysozyme gene in the BamBI site
ofpACYCI84, T7lysozyme was made available to the cell (15). A plasmid containing the
pLysS fragment will accumulate only low levels of the lysozyme. It has little effect on
growth rate and will not interfere with transformation of cells that contain the pLysS. The
low level of lysozymes due to pLysS had minimal effect on expression of target genes after
induction of T7 RNA polymerase. It is thought in literature that more T7 RNA polymerase
is induced than can be inhibited by the low levels of lysozyme.
Another useful feature of the pLysS was that it provided tolerance for BL21(DE3) from
plasmids with toxic inserts. Moreover, unstable plasmids became stable, and plasmids that
would not otherwise be established can be maintained and expressed. Finally, pLysS
served to ease the crude extraction of soluble protein. Once the recombinant vitronectin
accumulated, the cells were collected and suspended in a buffer consisting of 50mM Tris
HCI, 2mM EDTA, pH 8.0. This mixture underwent a freeze-thaw cycle to allow the T7
lysozyme present to lyse the cells. This technique proved to be useful in obtaining the
soluble recombinant protein (10).
In order to find the optimum conditions for expressions of soluble conditions, different

conditions for growth were used. Since proteins have unique characteristics, a wide range
of characteristics was established for testing. The pET Manual hypothesized that incubation
at 37°C caused some proteins to accumulate as inclusion bodies, yet growth at 25°C or 30°C
may be optimal for the production of soluble proteins (10). Moreover, Dr. Jonathan King
of M.I.T. suggested at a lecture that temperatures as low as 18°C may be best in recovering
soluble target protein (16). The retarding of the protein folding at low temperatures was
suspected to increase the amount of target protein in soluble form. Also, growth in high
salt (O.4M NaCI) media provides an enviroment with differnet ionic strenght that may be
suitable for better expression of the soluble form of recombinant vitronectin.
As Dr. King suggested, the 18°C cultures provided the greatest amount of soluble
vitronectin. Large scale samples of 200 mLs were grown at 18°C to produce a greater
quantity of the soluble recombinant vitronectin.

From the results of the SDS

polyacrylamide and Western blot analysis, it appears that the soluble form of the C-terminal
domain is present. Although the 24 hour samples revealed that most of the recombinant
vitronectin protein was in the urea pellet or otherwise inclusion bodies, the pET Manual
reports that even when most of the target protein mass is in aggregates there may be a
significant amount of soluble material as well (12). In this experiment, there did seem to be
a significant amount of soluble recombinant vitronectin present.
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In future experiments, the supernatant recovered from the sonication and crude
extractions will have to undergo several purification steps. After the purification steps, the
activity of the C-terminal domain will be analyzed in order to determine if the target protein
has been folded correctly. It is important to note that the presence of soluble vitronectin
does not indicate that the protein has been folded properly (10). It is possible that the
soluble aggregates formed will be inactive. Once the activity has been tested, the presence
of a soluble recombinant carboxy-terminal domain of vitronectin will be confirmed. The
production of a soluble form of the recombinant carboxy-terminal domain of vitronectin
will be a great value to further research. Later it will be possible to perform site-directed
mutagenesis or protein truncation, which will be useful in further characterizing the
interactions of vitronectin.
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